Swiss National Bank boosted its stake in Chemed Co. (NYSE:CHE – Free Report) by 1.9% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 32,700 shares of the company’s stock after purchasing an additional 600 shares during the quarter. Swiss National Bank’s holdings in Chemed were worth $17,713,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Fifth Third Bancorp boosted its holdings in shares of Chemed by 0.5% during the 2nd quarter. Fifth Third Bancorp now owns 3,893 shares of the company’s stock valued at $2,109,000 after buying an additional 20 shares in the last quarter. Asset Management One Co. Ltd. raised its position in shares of Chemed by 20.0% in the 2nd quarter. Asset Management One Co. Ltd. now owns 120 shares of the company’s stock worth $65,000 after purchasing an additional 20 shares during the last quarter. Ballentine Partners LLC raised its position in shares of Chemed by 3.4% in the 2nd quarter. Ballentine Partners LLC now owns 639 shares of the company’s stock worth $346,000 after purchasing an additional 21 shares during the last quarter. Fiduciary Planning LLC raised its position in shares of Chemed by 1.0% in the 2nd quarter. Fiduciary Planning LLC now owns 2,211 shares of the company’s stock worth $1,198,000 after purchasing an additional 21 shares during the last quarter. Finally, Deutsche Bank AG raised its position in shares of Chemed by 0.5% in the 1st quarter. Deutsche Bank AG now owns 4,893 shares of the company’s stock worth $2,631,000 after purchasing an additional 22 shares during the last quarter. Institutional investors own 94.25% of the company’s stock.
Insider Activity at Chemed
In related news, CEO Kevin J. Mcnamara sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 31st. The stock was sold at an average price of $560.68, for a total transaction of $2,803,400.00. Following the completion of the transaction, the chief executive officer now directly owns 112,968 shares in the company, valued at approximately $63,338,898.24. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Chemed news, EVP Spencer S. Lee sold 1,217 shares of Chemed stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $583.85, for a total value of $710,545.45. Following the sale, the executive vice president now directly owns 23,633 shares in the company, valued at approximately $13,798,127.05. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 5,000 shares of Chemed stock in a transaction on Tuesday, October 31st. The shares were sold at an average price of $560.68, for a total transaction of $2,803,400.00. Following the completion of the sale, the chief executive officer now owns 112,968 shares in the company, valued at $63,338,898.24. The disclosure for this sale can be found here. In the last ninety days, insiders sold 21,031 shares of company stock worth $12,157,220. 4.03% of the stock is owned by company insiders.
Chemed Stock Down 0.7 %
Chemed (NYSE:CHE – Get Free Report) last released its quarterly earnings results on Wednesday, October 25th. The company reported $5.32 EPS for the quarter, beating the consensus estimate of $4.92 by $0.40. Chemed had a net margin of 10.99% and a return on equity of 32.87%. The firm had revenue of $564.53 million during the quarter, compared to analyst estimates of $558.42 million. During the same quarter in the prior year, the firm earned $4.74 EPS. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Chemed Co. will post 19.3 EPS for the current year.
Chemed Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 4th. Investors of record on Monday, November 13th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.27%. Chemed’s dividend payout ratio (DPR) is presently 9.91%.
Analysts Set New Price Targets
Several research firms have recently issued reports on CHE. StockNews.com assumed coverage on Chemed in a research report on Thursday, October 5th. They issued a “buy” rating for the company. Royal Bank of Canada boosted their target price on Chemed from $576.00 to $604.00 and gave the stock an “outperform” rating in a research report on Monday, October 30th.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
- Five stocks we like better than Chemed
- How to Effectively Use the MarketBeat Ratings Screener
- S&P 500’s Whirlwind: Big gains, warning whispers & tactical moves
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 11/13 – 11/17
- How to Invest in Hotel Stocks
- 3 large caps with red hot RSIs with upside
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.